Explore 3 Stock Ideas & Industry Insights Download Free Report

News

What's Next for Innovation Pharmaceuticals (OTC: IPIX)? Stock Waits for Its Next Signal

Few tickers illustrate the extreme end of small-cap biotech quite like Innovation Pharmaceuticals. Trading at a fraction of a penny on the over-the-counter market, Innovation Pharmaceuticals Inc (OTC: IPIX) is a clinical-stage company whose long-running drug candidate has generated scientific interest but little recent …

Nitish Kishor | 10 September 2026

IRIDEX (NASDAQ:IRIX) Stock: Glaucoma Strength Meets Retina Weakness

IRIDEX Corporation (NASDAQ:IRIX) has spent much of 2026 stuck in a narrow, low-priced trading band, and the latest session did little to disturb that pattern. Trading around $0.68 near the bottom of its 52-week range, the ophthalmic device maker looks like a company caught …

Nitish Kishor | 10 September 2026

InMode (NASDAQ:INMD) Shares Hold Steady: What Could Break the Deadlock?

● Unlike most names generating attention through dramatic swings, InMode has been notable for how little its shares have moved, hovering near $14.79 while a boardroom-level tug-of-war plays out beneath the surface.

Nitish Kishor | 10 September 2026

Inovio Pharmaceuticals (NASDAQ:INO) Stock Retreats: What Could Turn It Around?

● Inovio Pharmaceuticals is approaching one of the most consequential moments in its long history, with a key regulatory decision on its lead DNA medicine drawing near.

Nitish Kishor | 10 September 2026

Top Healthcare Stock Watch: What Could Drive Insmed (NASDAQ:INSM) Next?

● Insmed has transformed itself from a one-product rare-disease company into one of the most closely followed names in mid-to-large-cap biopharma.

Nitish Kishor | 10 September 2026

Inspire Medical Systems, Inc (NYSE:INSP) Jumps: Why It Is Suddenly on Investors' Radar

● The advance coincided with Inspire's scheduled presentation at the Wells Fargo 21st Annual Healthcare Conference on 9 September, where management reiterated an outlook for sequentialRevenuegrowth in the second half and emphasised newer closed-loop technology and clearer reimbursement coding.

Nitish Kishor | 10 September 2026

Intensity Therapeutics (NASDAQ:INTS) Drifts Lower: Is the Pullback Creating a New Setup?

● Based in Westport, Connecticut, Intensity Therapeutics is a clinical-stage biotechnology company developing intratumoral cancer therapies designed to kill tumours locally while triggering a systemic anti-tumour immune response.

Nitish Kishor | 10 September 2026

The Company Behind OTC:IGRW Is Named Interactive Health Network. It Sells Incense.

The ticker IGRW (OTC:IGRW) is attached to a corporate name, Interactive Health Network, that hints at digital health or medical services. TheBusinessbehind the symbol is far more ordinary: it operates as House of Mohan, a distributor of incense, with shares changing hands at essentially …

Nitish Kishor | 10 September 2026

ImageneBio (NASDAQ: IMA) Stock Eases Back: Key Levels and Catalysts to Watch

ImageneBio, Inc. (NASDAQ: IMA) has quietly become one of the more intriguing names in inflammatory-disease drug development, backed by a well-capitalizedBalance Sheetand a lead antibody aimed at large dermatology markets. The stock, trading onNasdaqunder IMA, slipped modestly in recent action, but that small wobble …

Nitish Kishor | 10 September 2026

IMV (OTC:IMVIF) Stock: What Remains After Its Delisting and Asset Sale to BioVaxys

The story behind ticker IMV (OTC:IMVIF)IF is less an active market opportunity than a cautionary corporate epilogue. IMV Inc., once a Nova Scotia-based clinical-stage immuno-oncology company, is no longer an operating business.

Nitish Kishor | 10 September 2026
Support

Hi! How can we help you today?

Loading…